vix.ing · top · new · best · stats · spec

Developing a novel therapeutic strategy against cancer stem cell heterogeneity and plasticity

2024/09/27 by Tôru Kondo · 1 voice
Medicine · Engineering · Biochemistry, Genetics and Molecular Biology · #Cancer Cells and Metastasis #3D Printing in Biomedical Research #FOXO transcription factor regulation

paper · pdf · doi:10.47248/chp2401010006

openalex publication_date 2024/09/27 · openalex created_date 2025/10/10 · openalex updated_date 2026/06/22

Abstract

Cancer consists of heterogeneous cells, including cancer stem cells (CSCs), cancer cells, and tumor-associated cells, such as immune cells and vascular cells. Considering that these diverse cell types influence one another directly and indirectly through membrane proteins and secretion factors, such as exosomes and growth factors, the overall heterogeneity affects tumorigenicity and resistance to therapy. This review explores cancer heterogeneity, focusing on CSC heterogeneity, and discussed how the heterogeneity emerges by the intrinsic mechanism and the external factors and affects response to therapy. Additionally, as a potential therapeutic strategy to address this heterogeneity, I propose new Adeno-associated virus carrying a miRNA-dependent CSC eradication system that targets all types of CSCs with minimizing side effects.

Discussions

Related